URB2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.658600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.526200E-01
Normal-vs-Stage2
7.418600E-01
Normal-vs-Stage3
3.521400E-01
Normal-vs-Stage4
2.362800E-01
Stage1-vs-Stage2
3.741200E-01
Stage1-vs-Stage3
5.403500E-02
Stage1-vs-Stage4
4.568800E-01
Stage2-vs-Stage3
1.163030E-01
Stage2-vs-Stage4
9.336100E-02
Stage3-vs-Stage4
1.975720E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.839600E-01
Normal-vs-AfricanAmerican
2.256600E-01
Normal-vs-Asian
7.498400E-01
Caucasian-vs-AfricanAmerican
5.409600E-02
Caucasian-vs-Asian
2.803400E-01
AfricanAmerican-vs-Asian
1.608340E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.215000E-01
Normal-vs-Female
6.893200E-01
Male-vs-Female
5.414400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.700400E-01
Normal-vs-Age(41-60Yrs)
6.779000E-01
Normal-vs-Age(61-80Yrs)
8.129400E-01
Normal-vs-Age(81-100Yrs)
8.557400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.808200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.606200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.058000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.432600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.742800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.257400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.963200E-01
Normal-vs-Daily Drinker
6.285800E-01
Normal-vs-Weekly Drinker
5.022000E-01
Normal-vs-Occasional Drinker
8.664800E-01
Normal-vs-Social Drinker
5.112800E-01
Non Drinker-vs-Daily Drinker
2.725400E-01
Non Drinker-vs-Weekly Drinker
1.081010E-01
Non Drinker-vs-Occasional Drinker
7.540600E-01
Non Drinker-vs-Social Drinker
1.372360E-01
Daily Drinker-vs-Weekly Drinker
2.876400E-02
Daily Drinker-vs-Occasional Drinker
1.762790E-01
Daily Drinker-vs-Social Drinker
3.008400E-02
Weekly Drinker-vs-Occasional Drinker
2.310400E-01
Weekly Drinker-vs-Social Drinker
8.432200E-01
Occasional Drinker-vs-Social Drinker
2.301400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.149000E-01
Normal-vs-Grade 2
1.360620E-01
Normal-vs-Grade 3
1.240830E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.695600E-01
Grade 1-vs-Grade 3
6.041000E-01
Grade 1-vs-Grade 4
3.149000E-01
Grade 2-vs-Grade 3
5.875600E-01
Grade 2-vs-Grade 4
1.360620E-01
Grade 3-vs-Grade 4
1.240830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.968600E-01
Normal-vs-NonDiabetic
8.665800E-01
Diabetic-vs-NonDiabetic
6.052000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.510600E-01
Normal-vs-NoPancreatitis
8.508600E-01
Pancreatitis-vs-NoPancreatitis
6.224400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.813800E-01
Normal-vs-N1
7.389800E-01
N0-vs-N1
8.637600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.159000E-01
Normal-vs-TP53-NonMutant
6.648800E-01
TP53-Mutant-vs-TP53-NonMutant
4.034800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
